Caris Life Sciences, Inc. SEC filings CAI
Caris Life Sciences, Inc. has 134 filings in SEC EDGAR's recent list, going back to Jun 10, 2024. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 4 | Insider transaction | Sep 23, 2026 | Sep 22, 2026 |
| 144 | Notice of proposed sale | Sep 22, 2026 | — |
| 4 | Insider transaction | Sep 17, 2026 | Sep 17, 2026 |
| 144 | Notice of proposed sale | Sep 17, 2026 | — |
| 4 | Insider transaction | Sep 4, 2026 | Sep 3, 2026 |
| 144 | Notice of proposed sale | Sep 4, 2026 | — |
| 144 | Notice of proposed sale | Sep 3, 2026 | — |
| 144 | Notice of proposed sale | Aug 24, 2026 | — |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| 144 | Notice of proposed sale | Aug 7, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 7, 2026 | — |
| 144 | Notice of proposed sale | Aug 3, 2026 | — |
| 4 | Insider transaction | Jul 13, 2026 | May 15, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2026 | — |
| 4 | Insider transaction | May 12, 2026 | May 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 7, 2026 | — |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 5, 2026 | — |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 10, 2025 |
| 144 | Notice of proposed sale | Dec 11, 2025 | — |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Sep 12, 2025 | Sep 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 24, 2025 | — |
| 4 | Insider transaction | Jun 23, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Mar 25, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
| 3 | Initial insider ownership | Jun 17, 2025 | Jun 17, 2025 |
Showing 87 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- CAI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Irving, TX
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2019410
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
- CareDx, Inc. CDNA
Source: SEC EDGAR filings. This is company-reported data, not investment advice.